NDAC meeting date canceled
This article was originally published in The Tan Sheet
Executive Summary
Meeting of FDA's Nonprescription Drugs Advisory Committee that was to be held July 27 jointly with the Drug Abuse Advisory Committee has been canceled. Past joint meetings of the two committees have focused on smoking cessation products ("The Tan Sheet" May 26, p. 11). NDAC is scheduled to proceed with its July 28 and 29 meetings to discuss, respectively, labeling of vaginal antifungal products and healthcare antiseptic testing requirements...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning